EU
The article highlights the key points related to the regulatory status of legacy devices.
EU
The new article provides additional clarifications regarding specific aspects of the regulatory approach to be followed.
EU
The article highlights the key points related to the regulatory status of in vitro diagnostic medical devices under the existing legal framework.
EU
The final article of the cycle is dedicated to combination products and their specific regulatory nature.
EU
The new article further elaborates on the key matters associated with substance-based products intended to be marketed and used within the EU.
EU
The new article describes in detail the regulatory status of herbal products.
RegDesk is recognized as a Regulatory Intelligence Representative Vendor! Learn more by reading the 2024 Gartner® Market Guide for Regulatory Intelligence Solutions.
Get the report
